Project description:The transcriptome of Escherichia coli K-12 has been widely studied over a variety of conditions for the past decade while such studies involving E. coli O157:H7, its pathogenic cousin, are just now being conducted. To better understand the impact of intracellular life within a ruminant and environmental protozoan on E. coli O157:H7, global transcript levels of strain EDL933 cells inside Acanthamoeba were compared to cell grown in the protozoan media (ATCC PYG712) by microarray.
Project description:Escherichia coli (ATCC 25922) was cultured with sub-inhibitory doses of ZnO and ZnO nanoparticles for up to 40 subculture cycles, and the effect on the bacteria proteome was analyzed.
Project description:Primary objectives: The study investigates whether a Escherichia coli Nissle-suspenison has a (preventive) antidiarrheal effect in patients with tumors who are treated with chemotherapeutic schemes which are associated with increased occurances of diarrhea. Diarrhea caused by treatment are thought to be reduced in intensity and/or frequency by the treatment with Escherichia coli Nissle-Suspension.
Primary endpoints: Common toxicity criteria (CTC) for diarrhea
Project description:The purpose of this study is to determine whether the presence of pathogenic Escherichia coli in colon is associated with psychiatric disorders.
Project description:This project provides tandem mass spectrometry datasets of an artificial mixture used to optimize the lysis and evaluate digestion protocols for a fast preparation of peptides for tandem mass spectrometry proteotyping. The microorganism mixture is composed of Bacillus subtilis subsp. spizizenii ATCC 6633, Escherichia coli BL21-Gold(DE3)pLysS AG and Saccharomyces cerevisiae S288C.
Project description:E. coli K-12 ATCC 25404 in LB medium with 5-fluorouracil 10 uM biofilm cells relative to E. coli K-12 ATCC 25404 in LB DMF biofilm cells. The same amount of stock 5-fluoroacil stock solution (0.1% of the volume) was added as DMF into the LB DMF.
